In the United States, the cost of prescription drugs – even after discounts – rose over three times faster than the rate of inflation during the past decade, according to a study published in the Journal of the American Medical Association.
Given that the pharmaceutical industry is an investment industry driven by the profits of its shareholders, it is hardly surprising that drug prices in the United States are rising far faster than inflation. Profit, not improving human health, is the main driving force of pharmaceutical companies. As a result, global spending on drugs is expected to reach a staggering total of $1.4 trillion this year.
But lowering drug prices alone will not bring the pharmaceutical ‘business with disease’ to an end. The reason for this is that drugs don’t address the primary causes of diseases, only their symptoms. Ensuring the continued existence of diseases and expanding their incidence are preconditions for the financial growth of pharmaceutical companies. For true prevention and control of diseases, it is necessary to look elsewhere for answers.
In contrast to the dead-end of drug-based medicine, Dr. Rath’s groundbreaking Cellular Medicine research has shown that the primary cause of chronic diseases – including various forms of cardiovascular diseases, cancer, diabetes, and others – is a chronic deficiency of vitamins, minerals, amino acids, and other essential micronutrients. His science-based Cellular Medicine approach therefore defines an optimum daily intake of specific micronutrients as a basic preventative measure for maintaining health, and the effective, safe control of many pathological conditions.
To learn more about Dr. Rath’s groundbreaking Cellular Medicine approach to health, visit the special Cellular Medicine feature page on our website.